Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
12 June 2006Website:
http://www.atecspine.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 23:46:25 GMTDividend
Analysts recommendations
Institutional Ownership
ATEC Latest News
Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript
Alphatec (ATEC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago.
In recent years, Alphatec Holdings has outperformed expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company is capitalizing on M&A-related disruptions at key competitors, which has created opportunities for Alphatec to grab additional market share. Persistent cash usage has resulted in substantial debt accumulation and material dilution for common shareholders, but the company appears adequately financed to reach cash flow breakeven by 2025.
Alphatec Holdings, Inc.'s focus on growth rather than improving margins raises caution for investors. Despite strong revenue growth, the company continues to experience substantial losses and slow progress on margin improvements. The recent share sales and high debt levels contribute to investor uncertainty about the company's commitment to shareholder value.
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Pat Miles - Chairman and Chief Executive Officer Todd Koning - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Matt Blackman - Stifel Matthew O'Brien - Piper Sandler Joshua Jennings - TD Cowen Drew Ranieri - Morgan Stanley Sean Lee - H.C. Wainwright Jason Wittes - ROTH Operator Good afternoon, everyone and welcome to the webcast of ATEC's Third Quarter Financial Results.
Alphatec just priced an offering of 14.3 million shares at $10.50 per share -- a more than 18% discount from yesterday's close. The offering was filed pursuant to a previously filed shelf registration statement by the company.
Alphatec Holdings' Q2 numbers were strong, posting another double-digit upside at the top line. The company's surgical segment, particularly the LTP procedure, shows promise for growth and profitability in my view. Sentiment towards Alphatec's stock is mixed, with bullish positioning in the short-term but potential downside in the long term.
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Matt Blackman - Stifel Josh Jennings - TD Cowen Andrew Ranieri - Morgan Stanley David Saxon - Needham & Co. Aaron Wukmir - Lake Street Capital Markets Sean Lee - H.C. Wainwright Operator Good afternoon, everyone.
Alphatec (ATEC) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.36 per share a year ago.
Medical technology company sees 20% long-term growth as it expands into new global markets. Management projects positive cash flow in 2025.
What type of business is Alphatec Holdings?
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
What sector is Alphatec Holdings in?
Alphatec Holdings is in the Healthcare sector
What industry is Alphatec Holdings in?
Alphatec Holdings is in the Medical Devices industry
What country is Alphatec Holdings from?
Alphatec Holdings is headquartered in United States
When did Alphatec Holdings go public?
Alphatec Holdings initial public offering (IPO) was on 12 June 2006
What is Alphatec Holdings website?
https://www.atecspine.com
Is Alphatec Holdings in the S&P 500?
No, Alphatec Holdings is not included in the S&P 500 index
Is Alphatec Holdings in the NASDAQ 100?
No, Alphatec Holdings is not included in the NASDAQ 100 index
Is Alphatec Holdings in the Dow Jones?
No, Alphatec Holdings is not included in the Dow Jones index
When does Alphatec Holdings report earnings?
The next expected earnings date for Alphatec Holdings is 02 August 2024